# FDA Inspection 1066302 - Dario D. Altamirano, DO - September 21, 2018

Source: https://www.keypedia.com/records/fda_inspections/dario-d-altamirano-do/49ae984b-e792-4681-af3d-2e79ffefe8df
Source feed: FDA_Inspections

> FDA Inspection 1066302 for Dario D. Altamirano, DO on September 21, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1066302
- Company Name: Dario D. Altamirano, DO
- Inspection Date: 2018-09-21
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1279838 - 2025-08-21](https://www.keypedia.com/records/fda_inspections/dario-d-altamirano-do/5a9bd490-dedc-4182-8869-6ba2d321c59c)
- [FDA Inspection 1279838 - 2025-08-21](https://www.keypedia.com/records/fda_inspections/dario-d-altamirano-do/11f948f1-f684-449f-a623-91eb50fa0d33)
- [FDA Inspection 1161913 - 2022-02-09](https://www.keypedia.com/records/fda_inspections/dario-d-altamirano-do/0ffb1049-ef28-40c3-bad7-75a117488dca)
- [FDA Inspection 838564 - 2013-06-28](https://www.keypedia.com/records/fda_inspections/dario-d-altamirano-do/2ce30f32-aa95-4a50-9f05-092ba1d0f1aa)
- [FDA Inspection 754975 - 2011-11-03](https://www.keypedia.com/records/fda_inspections/dario-d-altamirano-do/5f30fdc9-ff94-42e3-8a63-038c999f77ca)

Company: https://www.keypedia.com/companies/dario-d-altamirano-do/3edb2aaf-26c5-417d-bd2a-35cb8d56cfc2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
